Single intravenous dose of oritavancin for treatment of acute skin and skin structure infections caused by gram-positive bacteria: Summary of safety analysis from the phase 3 SOLO studies

  1. Corey, G.R.
  2. Loutit, J.
  3. Moeck, G.
  4. Wikler, M.
  5. Dudley, M.N.
  6. O'Riordan, W.
  7. Abete, J.F.
  8. Altmeyer, P.
  9. Basson, M.D.
  10. Bezrodnyi, B.G.
  11. Brennan, R.O.
  12. Bubnova, N.A.
  13. Chandra, A.
  14. Chandrasekharan, A.A.
  15. Chen, J.
  16. Condrea, C.
  17. Del Rayo Morfin, M.
  18. DeValle, O.
  19. Dunbar, L.
  20. Duttarroy, D.
  21. Giordano, P.
  22. Gonzalez, J.
  23. Gorgolas, M.
  24. Graham, D.R.
  25. Green, S.
  26. Gudz, I.
  27. Gupta, S.K.
  28. Heller, B.N.
  29. Hussein, O.
  30. Jauregui-Peredo, L.
  31. Kabler, H.
  32. Kazimir, M.
  33. Keech, R.C.
  34. Kelkar, D.
  35. Konychev, A.V.
  36. Koura, F.
  37. Kozlov, R.S.
  38. Laboranti, M.C.
  39. Lakhani, R.J.
  40. Lee, P.C.
  41. Leiman, D.
  42. Leiva, J.
  43. Lenskaya, L.G.
  44. Levchik, E.Y.
  45. Lombana-Martinez, C.
  46. Lucasti, C.
  47. Mahakalkar, C.C.
  48. Mannis, S.H.
  49. Manos, P.J.
  50. Marinescu, S.A.
  51. Mayakonda, R.K.
  52. McKinnell, J.
  53. Mehra, P.
  54. Minkowitz, H.
  55. Nagappa, Y.C.
  56. Nolan, P.
  57. Osiyemi, O.
  58. Overcash, J.S.
  59. Porwal, A.D.
  60. Pullman, J.
  61. Pyptiuk, O.
  62. Perez, N.Q.
  63. Rahav, G.
  64. Ramachandra, H.T.
  65. Reinhardt, J.
  66. Riesenberg, K.
  67. Rodoman, G.
  68. Romero-Cabello, R.
  69. Rozario, A.P.
  70. Shah, M.Y.A.S.
  71. Sandesc, D.
  72. Schlesinger, Y.
  73. Sears, W.K.
  74. Shapoval, S.D.
  75. Shulutko, A.
  76. Sims, M.
  77. Singh, R.
  78. Stenstrom, R.J.
  79. Tuckler, V.
  80. Voigt, D.
  81. Zaichuk, A.
  82. Zeltser, D.
  83. Zubareva, N.A.
  84. Montrer des auteurs +
Revue:
Antimicrobial Agents and Chemotherapy

ISSN: 1098-6596 0066-4804

Année de publication: 2018

Volumen: 62

Número: 4

Type: Article

DOI: 10.1128/AAC.01919-17 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable